Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cells

Scott McComb(Institute for Biological Sciences), Mehdi Arbabi‐Ghahroudi(University of Ottawa)
Antibody Therapeutics
June 11, 2025
Cited by 0


Related Papers